Scilex Holding Co
SCLX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001820190
No open-market purchases or sales by Scilex Holding Co insiders were filed in the last 90 days; 73 institutions reported holding it in 13F filings for Q2 2026, worth $5.48M in total; no superinvestor holds it.
Other share classesSCLXW
Holders of 5% or more of SCLX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Scilex Holding Co, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| SCLX Stock Acquisition JV LLC | 13D/A | 21.10%80.6M shares | −1.70 ppfrom 22.80% | Jan 6, 20252 filings | Jan 23, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
7 Schedule 13D and 13G filings on Scilex Holding Co, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 20264:10 PM ET | Oramed Pharmaceuticals Inc. | 13G/A | 4.90%437.5K shares | −5.00 ppfrom 9.90%Below 5% | Dec 31, 2025 | SEC |
| Nov 14, 20254:30 PM ET | Oramed Pharmaceuticals Inc. | 13G/A | 9.90%833.5K shares | 0.00 ppfrom 9.90% | Sep 30, 2025 | SEC |
| Aug 14, 20256:56 PM ET | Oramed Pharmaceuticals Inc. | 13G/A | 9.90%764.3K shares | 0.00 ppfrom 9.90% | Jun 30, 2025 | SEC |
| May 8, 20254:15 PM ET | Oramed Pharmaceuticals Inc. | 13G/A | 9.90%732.7K shares | +3.70 ppfrom 6.20% | Mar 31, 2025 | SEC |
| Jan 23, 20259:21 PM ET | SCLX Stock Acquisition JV LLC | 13D/A | 21.10%80.6M shares | −1.70 ppfrom 22.80% | Jan 21, 2025 | SEC |
| Jan 17, 20254:15 PM ET | Oramed Pharmaceuticals Inc. | 13G | 6.20%15.5M shares | New | Jan 13, 2025 | SEC |
| Jan 6, 20257:11 PM ET | SCLX Stock Acquisition JV LLC | 13D/A | 22.80%84.6M shares | – | Jan 2, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Scilex Holding Co shares.
No Form 144 notices for Scilex Holding Co are on file.